Evelo Biosciences, Inc.

WELLS FARGO & COMPANY/MN EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

402

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	0	0.0%	402	3/31/2023
2022 Q4	2/13/2023	1	0.0%	390	12/31/2022
2022 Q3	11/14/2022	1	0.0%	380	9/30/2022
2022 Q2	8/12/2022	0	0.0%	183	6/30/2022
2022 Q1	5/16/2022	6	0.0%	1,835	3/31/2022
2021 Q4	2/14/2022	76	0.0%	12,671	12/31/2021
2021 Q3	11/15/2021	0	0.0%	37	9/30/2021
2021 Q2	8/16/2021	1	0.0%	37	6/30/2021
2021 Q1	5/13/2021	535	0.0%	50,064	3/31/2021
2020 Q4	2/9/2021	508	0.0%	42,071	12/31/2020
2020 Q3	11/5/2020	192	0.0%	36,474	9/30/2020
2020 Q2	8/13/2020	180	0.0%	36,673	6/30/2020
2020 Q1	5/14/2020	41	0.0%	10,940	3/31/2020
2019 Q4	2/14/2020	105	0.0%	26,057	12/31/2019